Live Breaking News & Updates on Lerner Research

Stay updated with breaking news from Lerner research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Xylitol: Common low-calorie sweetener linked to heart attack and stroke in study

Xylitol is used in many reduced-sugar foods and consumer products such as gum and toothpaste. ....

United States , New York , Andrew Freeman , Matthew Tomey , Stanley Hazen , Carla Saunders , Drug Administration , World Health Organization , Calorie Control Council , American Heart Association , Lerner Research Institute , Human Health , National Jewish Health In Denver , Icahn School Of Medicine At Mount Sinai , Cleveland Clinic Center , Cardiovascular Diagnostics , Cleveland Clinic , Lerner Research , Mount Sinai Fuster Heart Hospital , New York City , Icahn School , American Heart , National Jewish Health , European Heart Journal ,

Niacin Side Effects: Can Too Much Affect Your Heart?

Niacin, also known as vitamin B3, is critical to cell development, but too much may raise heart risks. Learn more about the effects of too much niacin. ....

United States , Office Of Dietary Supplements , Cleveland Clinic Lerner Research Institute , National Institutes Of Health , Dietary Supplements , Cleveland Clinic , Lerner Research , National Institutes , Iacin Side Effects , Heart Health , Cardiovascular Risk , Iacin Flush , Vitamin B3 , Niacin Benefits , Hat Is Niacin ,

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and. ....

Amit Kumar , Suparna Mazumder , Anixa Biosciences , Vincent Tuohy , Justin Johnson , Mike Catelani , Anixa Biosciences Inc , National Cancer Institute , Department Of Inflammation , Moffitt Cancer Center , Cleveland Clinic Lerner Research Institute , Japan Patent Office , Innovative Breast Cancer Research , Cleveland Clinic , Cancer Vaccines , Ovarian Cancer Vaccines , Iris November Distinguished Chair , Lerner Research , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Health Care Amp Hospitals , Medical Pharmaceuticals , International Medical Approval ,

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,. ....

United States , San Antonio , Mike Catelani , Anixa Biosciences , Stephen Kilmer , Amit Kumar , G Thomas Budd , Vincent Tuohy , Cleveland Clinic Lerner Research Institute , Us Department Of Defense , Innovative Breast Cancer Research , Cleveland Clinic Cancer Institute , Department Of Inflammation , Moffitt Cancer Center , Anixa Biosciences Inc , Cleveland Clinic , Antonio Breast Cancer Symposium , Dose Level , Call Details , Iris November Distinguished Chair , Lerner Research , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and. ....

United States , Stephen Kilmer , Anixa Biosciences , Axel Ullrich , Mike Catelani , Jennifer Davis , Brian Leyland Jones , H Michael Shepard , Dennis Slamon , Robert Weinberg , Vincent Tuohy , Harvard Medical School , Innovative Breast Cancer Research , Anixa Biosciences Inc , Department Of Inflammation , Warren Alpert Foundation Prize , National Cancer Institute , Winship Cancer Centre , Cleveland Clinic Lerner Research Institute , Mcgill University , Health Science At Emory University , Moffitt Cancer Center , Antonio Breast Cancer Symposium , Call Details , Triple Negative Breast Cancer , Michael Shepard ,